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Background: Shigella flexneri is the major cause of bacillary dysentery in the developing countries. The
lipopolysaccharide (LPS) O-antigen of S. flexneri plays an important role in its pathogenesis and also divides
S. flexneri into 19 serotypes. All the serotypes with an exception for serotype 6 share a common O-antigen backbone
comprising of N-acetylglucosamine and three rhamnose residues. Different serotypes result from modification of the
basic backbone conferred by phage-encoded glucosyltransferase and/or acetyltransferase genes, or plasmid-encoded
phosphoethanolamine transferase. Recently, a new site for O-acetylation at positions 3 and 4 of RhaIII, in serotypes 1a,
1b, 2a, 5a and Y was shown to be mediated by the oacB gene. Additionally, this gene was shown to be carried by a
transposon-like structure inserted upstream of the adrA region on the chromosome.
Results: In this study, a novel bacteriophage Sf101, encoding the oacB gene was isolated and characterised from a
serotype 7a strain. The complete sequence of its 38,742 bp genome encoding 66 open reading frames (orfs) was
determined. Comparative analysis revealed that phage Sf101 has a mosaic genome, and most of its proteins were
>90% identical to the proteins from 12 previously characterised lambdoid phages. In addition, the organisation of
Sf101 genes was found to be highly similar to bacteriophage Sf6. Analysis of the Sf101 OacB identified two amino acid
substitutions in the protein; however, results obtained by NMR spectroscopy confirmed that Sf101-OacB was functional.
Inspection of the chromosomal integration site of Sf101 phage revealed that this phage integrates in the sbcB locus,
thus unveiling a new site for integration of serotype-converting phages of S. flexneri, and determining an alternative
location of oacB gene in the chromosome. Furthermore, this study identified oacB gene in several serotype 7a isolates
from various regions providing evidence of O-acetyl modification in serotype 7a.
Conclusions: This is the first report on the isolation of bacteriophage Sf101 which contains the S. flexneri O-antigen
modification gene oacB. Sf101 has a highly mosaic genome and was found to integrate in the sbcB locus. These
findings contribute an advance in our current knowledge of serotype converting phages of S. flexneri.
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The burden of bacterial dysentery due to shigellosis con-
tinues to be a major concern affecting more than 165
million people annually. S. flexneri is the primary cause
of endemic shigellosis prevalent in the developing coun-
tries, and is the most frequently isolated species world-
wide [1].* Correspondence: naresh.verma@anu.edu.au
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unless otherwise stated.In S. flexneri, the O-antigen structure of the LPS, is
one of the key virulence determinants required for its
pathogenesis and protection against the host defence [2].
The O-antigen of S. flexneri, with the exception of sero-
type 6, consists of a polysaccharide backbone comprised
of the repeating tetrasaccharide units (N-acetylglucosa-
mine and three rhamnose residues), and modifications
to the basic O-antigen backbone by the addition of glu-
cosyl, O-acetyl, or phosphoethanolamine groups to one
or more sugars, give rise to various different serotypes of
S. flexneri [3-6]. To date at least 19 serotypes of S. flex-
neri have been identified [7].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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O-antigen, gtrA, gtrB and gtr(type), are arranged in a
single operon known as the gtr cluster [8-13]. Whereas,
the acetylation is mediated by a single gene ‘oac’ encoding
O-acetyltransferase [14]. While the glucosylation is known
to occur on any of the sugar residues, oac-encoded
O-acetylation occurs at position 2 of RhaI residue. Ad-
ditionally, the glucosyl or the O-acetyl modification genes
are carried by bacteriophages, which mediate serotype-
conversion by integrating into the host chromosome [3].
Six such serotype converting phages have been identified:
SfI, SfII, SfIV, SfV, and SfX, which encode the gtr gene
cluster, and Sf6 which encodes the oac gene [10,15-18].
In contrast to the phage-encoded glucosylation and
O-acetylation, the phosphoethanolamine modification at
position 3 of RhaII and/or RhaIII, is encoded by a plasmid-
borne opt gene [6].
Recently, new sites for the O-acetylation of S. flexneri
O-antigen have been identified. These are O-acetylation at
position 3 (major) and 4 (minor) of RhaIII (3/4-O-acetyl-
ation) in serotypes 1a, 1b, 2a, 5a, Y, 6 and 6a, and at
position 6 of GlcNAc in serotype 2a, 3a, and Y [19-22].
Moreover, the degree of 3/4-O-acetylation has also been
shown to vary between the ranges 30-70% (at position 3)
and 15-30% (at position 4), within the strains of one
serotype [21]. Another recent study revealed that the
3/4-O-acetylation modification in S. flexneri is mediated
by the oacB gene, which was shown to be carried by a
transposon-like structure located upstream of the adrA
gene on the chromosome [23]. In this study, we report the
isolation and characterisation of a novel bacteriophage
Sf101, from a wild type serotype 7a strain, and show for
the first time that oacB gene was located on the intact
genome of the prophage, Sf101. The complete genome se-
quence of the Sf101 phage was determined. Comparative
genomics used for highlighting important genetic simi-
larities with other lambdoid phages indicated that the
Sf101 phage has a mosaic genome and Sf6-like genome
architecture. Analysis of a specific chromosomal integra-
tion site for phage Sf101 revealed that the phage integrates
into the sbcB locus, thus identifying a new site for the in-
tegration of the serotype converting phages of S. flexneri,
and a new location of oacB in S. flexneri chromosome.
Additionally, this study also identified oacB gene in several
serotype 7a isolates from various geographical regions,
suggesting that the 3/4-O-acetylation modification is not
uncommon in serotype 7a of S. flexneri.
Methods
Bacterial strains, bacteriophage and media
The induction of bacteriophage Sf101 from serotype 7a
S. flexneri strain SFL1683 was performed using UV irra-
diation protocol described by Adam et al. [8]. Bacterio-
phage stocks were prepared by picking a single plaque,propagating on serotype Y strain (SFL124) [24], and pre-
cipitating phage using polyethylene glycol, as described in
Sambrook et al. [25]. S. flexneri strain SFL1691 (serotype
7a) lacking the 3/4-O-acetylation on the RhaIII was used
as host for Sf101-OacB functional analysis. E. coli JM109
was used for cloning experiments.
Bacteria were grown in Luria–Bertani (LB) broth or LB
agar supplemented with Chloramphenicol (25 μg/ml) or
Erythromycin (250 μg/ml) when appropriate. NZCYM
broth was employed for routine propagation of phage.
DNA methods
Sf101 phage DNA was isolated from purified phage stock
by treatment with Proteinase K as described by Sambrook
et al. [24]. Bacterial genomic DNA was isolated using GE
Healthcare genomic DNA isolation kit (GE Healthcare),
according to the manufacturer’s instructions. Plasmid iso-
lation was performed using the Axyprep Plasmid Miniprep
kit (Axygen Biosciences). Primers used in this study were
synthesized by Sigma-Aldrich and are listed in Additional
file 1: Table S1. PCR amplification was performed using
the PfuUltra II Fusion HS DNA Polymerase (Stratagene)
according to the manufacturer’s directions. Purification of
the PCR products was achieved by using the Wizard SV
Gel and PCR Clean Up System (Promega). DNA sequen-
cing was performed using Big Dye Terminator v3.1 Cycle
Sequencing kit as recommended by the manufacturer and
were run on an AB 3730 capillary sequencer at Biomedical
Resources Facility, John Curtin School of Medical Re-
search, Australian National University.
Sf101 oacB was amplified using Sf101 phage DNA as
template, using primers Sf101-OacB-Fwd and Rev. The
purified product was then cloned into vector pBC SK +
(Stratagene) to generate plasmid pNV2073. Erythromycin
gene, PCR amplified from plasmid pTRKH2 using Em
primer pair was then cloned into pNV2073 to generate
plasmid pNV2074. The recombinant plasmids were trans-
formed by electroporation and maintained in JM109 cells.
pNV2074 was also introduced into S. flexneri strain
SFL1691 to produce SFL2516.
Electron microscopy
The purified phage was absorbed on carbon-coated cop-
per grids, negatively stained with 2% phosphotungstic
acid (pH 7.0) and visualized with a Hitachi H7000 trans-
mission electron microscope.
Host range determination
The host range of phage Sf101 was determined as de-
scribed previously [17]. Briefly, different dilutions of
phage stock were made in SM buffer; 5-10 μl of each
dilution was then spotted on required bacterial lawn on
an agar plate. Lytic activity (clear zone encompassing the
Figure 1 Electron micrograph of phage Sf101 negatively
stained with 2% phosphotungstic acid. Scale bar, 50 nm.
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tion at 37°C.
Sequencing of phage genomic DNA
The purified Sf101 phage DNA was sequenced using the
Ion Torrent PGM 314 chip (Life Technologies) at the
Australian Genome Resource Facility, University of
Queensland. The reads generated were assembled into
contigs using CLC Genomics Workbench (Ver 5.5.1,
CLC Bio). To close the gaps between the contigs and
re-sequence the regions of low-quality, the desired seg-
ments were PCR amplified using phage DNA as tem-
plate and the purified PCR products were sequenced as
described above.
Analysis of sequence
Open reading frames were determined using CLC Main
Workbench (Ver 5.5.1, CLC Bio) and NCBI ORF finder
program. Genes within orfs were predicted based on
homologies to the known genes found by BlastN and
BlastP searches and the presence of Shine-Dalgarno
ribosome binding sites. The Rho-independent termina-
tors were identified using ARLOND terminator finding
program [26] and tRNAscan-SE search server was used
to scan for tRNA [27].
The protein level alignments were performed using Clus-
talW [28] and BioEdit Sequence Alignment Editor [29].
The accession numbers for the phages used for compara-
tive genomics were: CUS-3 (CP000711), Sf6 (NC_005344),
HK544 (NC_019767), mEP043 c-1 (NC_019706), SfX
(NC_017328), mEp213 (NC_019720), mEp234 (NC_019
715), P22 (NC_002371), epsilon34 (NC_011976), Ime10
(NC_019501), HK446 (NC_019714), Phage 2851 (FM
180578).
Preparation of O-polysaccharide and NMR spectroscopy
Lipopolysaccharide of strains SFL1683, SFL1691 and
SFL2516 were isolated by the phenol water extraction of
dried bacterial cells [30]. Lipid-free polysaccharide (PS)
was prepared by treatment of the LPS with dilute acetic
acid followed by purification using gel permeation chro-
matography [31].
1H NMR spectra of the LPS in D2O solution were
recorded at 80°C on a Bruker Avance II 500 MHz
spectrometer. 1D and 2D NMR experiments [32] of the
PS were recorded in D2O solution on Bruker Avance
500 MHz and Bruker Avance III 700 MHz spectrome-
ters, equipped with 5 mm TCI Z-Gradient CryoProbes,
at 24°C for strain SFL1683 and at 20°C for strain
SFL2516. Data processing was performed using vendor-
supplied software. Chemical shifts are reported in ppm
using internal sodium 3-trimethylsilyl-(2,2,3,3-2H4)-pro-
panoate (TSP, δH 0.00) or external 1,4-dioxane in D2O
(δC 67.40) as references.Availability of supporting data
The nucleotide sequence of Sf101 phage reported in this
article has been deposited in the GenBank database as
accession number KJ832078.
Results and discussion
Isolation of Sf101
A novel bacteriophage named Sf101 was induced and
isolated from serotype 7a, strain SFL1683. Phage Sf101
formed clear, round plaques when plated onto the indi-
cator strain SFL124 (serotype Y). In order to confirm
that SFL1683 is the host strain of Sf101 phage, Southern
hybridization of HindIII digested genomic DNA of the
host, using DIG-labelled Sf101 as a probe was per-
formed. Results confirmed the presence of phage ge-
nome integrated into the host chromosome (data not
shown).
Morphology of Sf101
Electron microscopic examination of Sf101 phage prepar-
ation revealed that it has an isometric head (ca. 50 nm)
and a short tail (ca. 16 nm) (Figure 1). According to the
morphological classification of Bradley, these characteris-
tic features are typical of phage in the C group mor-
phology of the family Podoviridae and order Caudovirale
[33]. Among the other serotype converting phages of
Shigella, appearance of Sf101 phage resembles phage Sf6
and SfX [34,35].
Host range
Twelve serotypes (1a, 1b, 2a, 2b, 3a, 3b, 4a, 4b, 5a, 7a, X,
and Y) of S. flexneri were tested for sensitivity against
Sf101 phage. Together, Sf101 was able to infect 4
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some differences in the phage ability to form plaques on
different serotypes. Sf101 plating efficiency was similar
on serotypes Y and 1a; however, it was 105 fold lower
when plated on serotypes 3b and 1b. In a number of
short-tailed phages, adsorption is mediated by an initial
reversible binding of the phage to bacterial LPS, followed
by an irreversible attachment of the phage to an un-
known secondary receptor, the presence of which has
been found to be necessary for infection. Recently,
OmpA and OmpC were identified as the secondary re-
ceptors for bacteriophage Sf6, and were shown to dra-
matically affect the rate and efficiency of bacteriophage
Sf6 infections [36]. Bacteriophage Sf101 being similar to
Sf6 might also require presence of secondary receptors
for infection, and the difference in the plating efficien-
cies observed might be due to mutation in the secondary
receptors of these strains.
Genome properties and organisation
The complete genome of Sf101 phage was sequenced
using 314 chips on an Ion torrent PGM, producing an
average read length of approx. 125 bp. A total of approx.
21,069 reads were generated which were then de-novo
assembled into 6 major contigs using CLC Genomics
Workbench (Ver 5.5.1, CLC Bio). The accuracy of the
contigs was verified by mapping the reads back to the
contigs. The regions of ambiguity and the gaps between
the contigs were then addressed by targeted Sanger se-
quencing to obtain a single contiguous sequence.
The complete genome of Sf101 phage consists of
38,742 bp, with the overall G + C content of 47.4%. A
total of 66 protein coding genes with a plausible Shine-
Dalgarno sequence were predicted from the genome se-
quence. Among which 41 orfs are transcribed from the
sense strand and 25 are on the antisense strand. The
majority of the orfs initiate translation with an ATG,
whereas only 6 start with GTG. The sizes of the gene
products varied from 24 a.a. to 911 a.a.
The translated orf products were also compared with
known protein sequences using BlastP (Additional file 2:
Table S2). Based on the similarities, 43 out of 66 orfs
were assigned putative functions, while the other 23 orfs
exhibited similarity to uncharacterised proteins. The
overall genetic organisation of Sf101 phage (Figure 2a),
consisting of “DNA packaging and structure - serotype
conversion - regulation – recombination - replication –
nin and the lysis region”, suggested that this phage is a
member of lambdoid family. Additionally, the layout of
the genes was similar to that of previously sequenced
serotype converting Shigella phages Sf6 and SfX.
The Sf101 genes were generally tightly spaced occu-
pying 94.5% of the genome. However, there were several
large (~200 to 600 bp) apparently non-coding regionswithin the genome (e.g. between orfs 16-17, 17-18,
19-20, 23-24 and 37-38). Although no tRNA genes were
identified in these or other locations by using a tRNA
scanning program, several putative Rho-independent
transcription terminators were identified and are shown
in Figure 2a.
Relationship to other phages
Initial whole genome Blast of phage Sf101 against the
NCBI database showed that bacteriophage Sf101 is re-
lated to several lambdoid phages originating from va-
rious hosts, like S. flexneri, E. coli and Salmonella. To
better understand the relatedness, comparison of pro-
teins encoded by Sf101 phage to those of the 12 most re-
lated phages was carried out. Figure 3 shows that most
of the proteins encoded by the phage Sf101 were >90%
identical with proteins from previously characterised
lambdoid phages. Moreover, the genome of phage Sf101
is highly mosaic with the left half of the phage most
homologous to E. coli phage CUS-3 and the right half
most homologous to phage Sf6 and HK544.
The module containing DNA packaging and structural
proteins is the largest module of the Sf101 phage, and is
predicted to contain 15 orfs (orf 1 to 15). While the
packaging proteins of Sf101 were identical to Sf6, most
of the proteins responsible for phage head assembly
shared >90% identity with their counterparts in CUS-3
(Figure 3). One of the exceptions was ORF9 in the head
completion module. orf9 with two other genes of the
module encode for proteins required for stabilizing the
phage head after DNA gets loaded in it. Although, ORF9
shared only 50% identity with its equivalent in CUS-3, it
was found to be >90% identical to its homologue in
phage P22. The major difference between CUS-3 and
Sf101 head morphogenesis proteins, was in the DNA in-
jection module. Sf101 ORF11, 12 and 13, forming this
module showed only 85%, 34% and 32% identity to their
equivalents in CUS-3. In general, the injection proteins
are known to be more variable than the rest of the virion
assembly proteins because these proteins are released by
the virion during DNA injection and function in the
host during or after the injection [37].
orf15 of Sf101 encodes the tail spike protein that
adsorbs to the cell receptors (O-antigen) of the host.
Analysis of the tail spike protein of Sf101 phage revealed
conservation in the amino terminal portion than in the
carboxyl terminal region. The amino terminal residues
were homologous to the cognate amino acid residues of
CUS-3, Sf6, SfX, and epsilon34 (90, 90, 90, and 85%
identity, respectively). However, very limited homology
was observed between the carboxyl terminal residues.
The reason for this could be that the amino terminal do-
main of the P22 like tail spikes are known to bind to
virion head and is therefore more conserved. The
Figure 2 Genome map and integration site of phage Sf101. (a) The Sf101 genome is shown with a scale in bp. orfs are represented by
arrows oriented in the direction of transcription. Putative functional modules are indicated above the arrows. Black knobs below the scale depict the
Rho-independent terminators and the attachment site of the phage (attP) is indicated with a blue vertical arrow. (b) Schematic representation of
phage Sf101 integrative recombination where attP on the phage genome recombines with the attB within sbcB gene of S. flexneri chromosome to
form the two junction’s recombination sites attL and attR. Arrows P1 (sbcB-dwn-att-Fwd) and P2 (Orf22-up-Rev) on the map indicate the primers used
in the PCR.
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the O-antigen binding site and so is specific for each
phage [37,38]. The integrase of phage Sf101 (encoded by
orf18) shared 99% identity with the integrases of HK544,
mEp234 and phage 2851. Moreover, further analysis of
Sf101 genome sequence has revealed a 13 bp sequence
(5’CGTAATCGTGAAA 3’) located upstream of the int
gene, that is, identical to the attP of phage 2851 [39].
While the integration sites and attP sequence of HK544
and mEp234 are not known, phage 2851 has been shown
to integrate in the sbcB locus [39]. The extremely high
similarity of the Sf101 phage attP and Int protein to
those of phage 2851 suggested that the integration site
of Sf101 phage must be at the sbcB locus, identical to
phage 2851. We amplified and sequenced one of the
Sf101 prophage-bacterial genomic junctions that spansbetween Sf101 orf22 and sbcB gene (Figure 2b). A 3 kb
sequence was obtained in which 13 bp attL sequence
was identified; thus confirming the integration of Sf101
phage into the 5’ end of sbcB gene (encoding 3’-5’ exo-
nuclease). This is unlike all the other known serotype-
converting phages of S. flexneri which are known to
integrate either into the agrW or thrW tRNA gene
[10,15-18].
The early and regulatory regions located in the right
half of the genome shared homology to CUS-3, Sf6,
HK544, mEp043c-1, mEp213, mEp234 and HK446.
However, the proteins of regulation and the replication
module were most similar (>90% identical) to their cog-
nates in HK446 and mEp043c-1, respectively. The nin
region of the Sf101 phage (ORF46-54) was identical to
that of phage HK544, with ninX being the only
Figure 3 Comparison of Sf101 with related phages. Proteins encoded by Sf101 phage were compared with those of 12 other lambdoid
phages from E. coli, S. flexneri and Salmonella. The coloured arrows represent the level of amino acid sequence identity between Sf101 protein
and its counterpart in other phages. The red and green colours indicate >90% and >80% identity, respectively. The purple arrows on Sf101 map
represent proteins with no phage-borne homologue.
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G, H, and I of Sf101 phage were also conserved in Sf6,
mEp213, mEp234 and HK446 phages.
The antitermination Q and a set of predicted lysis
genes lie downstream of the nin region. The lysis mo-
dule of phage Sf101 is typical of lambdoid phages, con-
sisting of holin, anti-holin, lysin, Rz and Rz1 proteins
(encoded by orfs 57-61). Additionally, orf61 of Sf101
phage lies inside orf60, in a second reading frame, as in
other lamdoid phages [38]. Homologues of holin, anti-
holin, lysin, and Rz were seen in all the phages shown in
Figure 3, except for phage P22 and phage 2851. In
contrast, equivalents of Rz1 of phage Sf101 were only
present in CUS-3, Sf6, P22 and epsilon34. To the right
of the lytic cassette, orfs 62, 64, 65 and 66 encoded pro-
teins which shared >90% identity with their homologues
in SfX and Sf6, whereas orf63 encoded Rha family pro-
tein was identical to its cognate in phage CUS-3.Novel genes of Sf101 phage
Sf101 phage proteins encoded by orfs 16, 17, 41 and 56,
were identified as proteins with no known phage-borne
homologues. Whilst ORF17 and 56 shared similarity
with uncharacterised proteins of E. coli, ORF41 had no
homologue in E. coli or Shigella and showed limited
homology with proteins from Saprospira grandis and
Bipolaris maydis. BlastP results of ORF16 revealed that
it is an acyltransferase family protein, sharing 99% iden-
tity with the protein encoded by gene SF0315 (named
oacB) of S. flexneri 2a str 301. OacB has recently been
shown to confer the 3/4-O-acetylation modification of
RhaIII of S. flexneri O-antigen [23].
Pairwise alignments of Sf101 orf16 (Sf101-oacB) with
the oacB at the DNA and protein levels were carried out.
The analysis identified three base substitutions (G486 to
A, C692 to T and G796 to A) in the Sf101-oacB. While
the first mutation had no effect at the protein level, the
Figure 4 NMR. Selected regions of (a) 1H NMR spectrum of the PS
from strain SFL1683 showing resonances from O- and N-acetyl groups
and (b) 1H,1H-TOCSY (τmix 120 ms) NMR spectrum of the PS from strain
SFL2516 showing spin systems originating from the H6 protons in the
methyl groups of rhamnosyl residues. Annotations are given with
respect to the O-acetylation pattern in the O-antigen.
Jakhetia et al. BMC Genomics 2014, 15:742 Page 7 of 10
http://www.biomedcentral.com/1471-2164/15/742other two mutations resulted in two amino acid substitu-
tions in Sf101-OacB: A231 to V and V266 to I (Additional
file 3: Figure S1). Since, A, I and V are all neutral amino
acids with similar structure, it was expected that these
mutations will impose minimum effect on the function of
OacB. This was verified by performing NMR spectroscopy
experiments.
Confirming the function of Sf101-OacB
In order to confirm the function of Sf101-OacB, we first
analysed the LPS of the Sf101 host (SFL1683) by 1H NMR
spectroscopy. Results revealed NMR resonances at δH
2.21 and 2.17 indicating the presence of O-acetyl groups
[40,41]. oacB gene from Sf101 phage was then cloned into
a plasmid (pNV2074) and introduced into a serotype 7a
strain (SFL1691), which was PCR negative for oacB gene,
to create a recombinant strain SFL2516. The 1H NMR
spectrum acquired on the LPS of strain SFL2516 revealed
resonances, inter alia, at δH 2.21, 2.17 and 2.15; however,
NMR signals were absent in the spectral region for
O-acetyl groups for the SFL1691 LPS.
LPS of strains SFL1683 and SFL2516 were then treated
by dilute aqueous acetic acid and purified by size exclu-
sion chromatography to obtain the polysaccharide mate-
rials (PS). The 1H NMR spectra of these PS showed
resonances, inter alia, at δH 2.21 (0.8 H), 2.16 (0.5 H), 2.11
(0.9 H) and 2.07 (2.1 H) for the SFL1683 strain (Figure 4a)
and at δH 2.22 (0.8 H), 2.17 (0.7 H), 2.13 (0.8 H) and 2.08
(2.2 H) for the SFL2516 strain, indicating partial O-acetyl
substitution. The O-acetyl substitution position(s) were
then determined by performing the 1H,1H-TOCSY experi-
ments employing an array of mixing times of increasing
lengths, which have proven to be particularly powerful at
unraveling the spin-systems of the sugar residues and sub-
sequently the O-acetyl substitution position(s) [42]. Using
mixing times in the range 10–120 ms, the 1H,1H-TOCSY
spectra of the PS from strain SFL2516 revealed, inter alia,
spin systems originating from δH 1.29 (H6 of Rha
III3Ac) to
3.79 (H5), 3.53 (H4), 5.09 (H3) and 4.26 (H2), from δH
1.16 (H6 of RhaIII4Ac) to 3.86 (H5), 4.80 (H4), 4.10 (H3)
and 4.22 (H2), as well as from δH 1.26 (H6 of Rha
III) to
3.68 (H5), 3.34 (H4), 3.87 (H3) and 4.14 (H2) (Figure 4b).
The 1H,1H-TOCSY spectra of the PS from strain SFL1683
were closely similar, and taken together these results were
fully consistent with the NMR data reported by Wang
et al. [23] for partial O-acetyl substitution at positions O3
and O4 of RhaIII in O-antigens from other S. flexneri sero-
types. Thus, O-acetylation was present to about 1/4 at O3
and to about 1/5 at O4 in the two strains investigated
herein.
Identification of conserved residues and motifs of OacB
BlastP results of Sf101-OacB also revealed that this pro-
tein shared some homology with acyltransferases from
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the superfamily COG1835 (acyl_transf_3). Multiple align-
ment of the Sf101-OacB with 20 of its homologues from
various species was carried out for identification of the
conserved residues and motifs. Results of alignment
(Additional file 4: Figure S2) showed several conserved
motifs: DGxRGxLAxxVxxHH, FFxITG(YorF)LFxxK,
WxLxYEWxFY and YSXYLxHG (where x is any amino
acid), present at similar positions of the proteins. The
first 3 motifs were found in the amino terminal part of
the protein while the fourth one was in the carboxy
terminus. Several other conserved amino acids were
also identified in close proximity to these motifs. The
high levels of conservation of various amino acid motifs
suggests that they may be involved in specific conserved
functions.
Distribution of oacB in S. flexneri 7a strains
The 3/4-O-acetyl modification observed in this study was
in a serotype 7a strain. However, serotype 7a is known to
lack any O-acetyl modification to date [21]. Thus, several
serotype 7a isolates from different regions (4 from
Bangladesh, 9 from Egypt, 1 from Sweden, 31 from UK,
and 14 from Vietnam) were screened to identify a possible
3/4-O-acetylation modification. As the antiserum specific
for 3/4-O-acetyl modification was not available, a PCR
screening of 59 serotype 7a strains with oacB specific
primers was performed. As shown in Table 1 the expected
PCR product was amplified from 7 out of 59 strains
(1 isolate each from Sweden, UK, and Egypt, and 4 from
Bangladesh). The sequencing of the PCR product from
the positive strains revealed that the oacB gene sequence
in 2 strains (1 from Egypt and 1 from Sweden) was identi-
cal to oacB of Sf101 phage (Additional file 3: Figure S1).
However, the oacB gene in the other 5 strains was almost
identical to oacB from S. flexneri 2a str 301 except a base
substitution at position 1146, which resulted in I382 to M
mutation in the OacB protein of all 5 strains. However, as
I and M are neutral amino acids, this mutation is expected
to have no effect on the function of OacB. These results
suggest that the 3/4-O-acetyl modification in serotype 7a
is not uncommon. Moreover, in order to determine if
oacB gene in these 7a strains was carried by Sf101 phage,
PCRs targeting three different regions of Sf101 phageTable 1 PCR screening of oacB in serotype 7a isolates from va
Serotype 7a isolates
obtained from
Number of strains
screened
Number of
PCR positive
Bangladesh 4 4
Egypt 9 1
Sweden 1 1
UK 31 1
Vietnam 14 0(orf15-orf16, orf30-orf39, and orf60-orf66) were performed
on the above 7 oacB positive strains. Results revealed that
1 out of the 7 tested strains carried complete Sf101 phage
suggesting this phage may have contributed in the dissem-
ination of the oacB gene in 7a strains (Table 1).
Integration site of Sf101 phage suggests that the oacB
gene in Sf101 lysogens is located in the sbcB locus. How-
ever, the reported site for oacB gene in serotype 1a, 1b,
2a, 5a and Y is upstream of the adrA gene (which en-
codes diguanylate cyclase AdrA) [23]. Thus, the location
of oacB gene in the 7 oacB positive serotype 7a strains
was determined by performing PCR using primer spe-
cific for oacB gene and adrA. Results indicate that the
location of oacB in the Sf101 lysogen was the sbcB locus,
while in the other 6 strains oacB was located upstream
of the adrA gene. Change in the chromosomal position
of oacB from sbcB to adrA locus is likely due to disrup-
tion of the prophage by IS elements and mobilization of
oacB due to the combination of 2 or more IS elements
flanking oacB. This hypothesis is supported by our ana-
lysis of the region flanking sbcB gene in 10 previously
sequenced S. flexneri genomes obtained from the NCBI
database. Results revealed that the region upstream of
sbcB gene is extremely variable containing insertion ele-
ments in all, and Sf101 like Int in 8 out of 10 strains.
Taken together, our analysis indicate that a possible
presence and disruption of Sf101 phage by IS elements
could have resulted in the mobilization of oacB in some
and loss in the other strains. Additionally, Wang et al.
have also reported that the oacB gene located upstream
of adrA in serotypes 1a, 1b, 2a, 5a & Y was carried by a
transposon-like structure [23].
Conclusion
This study reports the isolation and characterisation of a
novel bacteriophage Sf101 from S. flexneri serotype 7a
strain. Complete genome sequence of Sf101 phage was
determined and found to contain functional oacB gene
making it a serotype converting phage of S. flexneri. The
comparative genomic analysis of Sf101 to 12 other
lambdoid phages revealed that bacteriophage Sf101 has a
highly mosaic genome and Sf6-like genome organisation.
Sf101 was found to integrate in the sbcB locus repre-
senting a new genomic location of oacB gene in Sf101rious regions
oacB
strains
Number of Sf101 phage
PCR positive strains
Location of
oacB
0 Upstream of adrA
1 sbcB
0 Upstream of adrA
0 Upstream of adrA
- -
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http://www.biomedcentral.com/1471-2164/15/742lysogen. Additionally, this study for the first time identi-
fied oacB gene in several serotype 7a isolates from differ-
ent regions, providing evidence of 3/4-O-acetylation
modification in serotype 7a of S. flexneri. These findings
will further our understanding on the serotype conver-
ting phages of Shigella which will be useful in com-
prehending the role these bacteriophages play in the
survival of S. flexneri in the environment and human
host.
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Additional file 1: Table S1. List of primes used in this study.
Additional file 2: Table S2. Analysis of predicted orfs and proteins of
Sf101.
Additional file 3: Figure S1. Multiple alignment of the amino acid
sequence of OacB from Sf101, S. flexneri 2a str 301, and 7 serotype 7a
strains performed using ClustalW. Amino acid substitutions in Sf101 OacB
when compared with OacB of S. flexneri 2a str 301 are boxed in green.
Residues highlighted in red are identical to OacB from Sf101, while the
ones in green share identity with OacB of S. flexneri 2a str 301. Residues
in grey are point mutations in the protein sequences of serotype 7a
strains.
Additional file 4: Figure S2. Alignment of Sf101 OacB with
homologues acyltansferases. The OacB protein from Sf101 phage was
aligned with its homologues in several other species using ClustalW.
Regions highlighted in pink are conserved amino acids. Conserved motifs
are shown by green lines above the alignment.
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